TPCO Holding (TPCO Holding) Debt-to-Asset : 0.23 (As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is TPCO Holding Debt-to-Asset?

TPCO Holding's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $2.06 Mil. TPCO Holding's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $58.55 Mil. TPCO Holding's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2023 was $258.80 Mil. TPCO Holding's debt to asset for the quarter that ended in Mar. 2023 was 0.23.

TPCO Holding Debt-to-Asset Historical Data

The historical data trend for TPCO Holding's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TPCO Holding Debt-to-Asset Chart

TPCO Holding Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

0.12

0.23

TPCO Holding Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Debt-to-Asset	Get a 7-Day Free Trial									0.13	0.13	0.20	0.23	0.23

Competitive Comparison of TPCO Holding's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, TPCO Holding's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TPCO Holding's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TPCO Holding's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where TPCO Holding's Debt-to-Asset falls into.

TPCO Holding Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

TPCO Holding's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(3.442	+	61.422)	/	280.518
	=	0.23

TPCO Holding's Debt-to-Asset for the quarter that ended in Mar. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(2.061	+	58.552)	/	258.804
	=	0.23

TPCO Holding (OTCPK:GRMWF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

TPCO Holding Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of TPCO Holding's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

TPCO Holding (TPCO Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TPCO Holding Corp (OTCPK:GRMWF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1550 Leigh Avenue, San Jose, CA, USA, 95125

Website

https://www.theparent.co

TPCO Holding Corp is a consumer-focused cannabis company based in the United States focused on the recreational and wellness markets. Its operational footprint spans cultivation, extraction, manufacturing, distribution, brands, retail and delivery. The company's sales channels include Direct Consumer and Wholesale, of which key revenue is derived from the Wholesale channel which includes the company selling first-party and selected third-party products into 450 dispensaries across California. Additional wholesale revenue comes from sales of sourced bulk flowers and oil produced in-house. It has one segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the State of California.